Dear List(s),

If you are in pain and still being given Neurontin consult with your
physician immediately. The FDA after fining the manufacturer
heavily including 2,000 suicides, and other irreversible physical
damage occurring using this drug in 90% of cases for "off label"
purposes, is demanding within six months that companies
marketing anti-seizure medication for "other purposes" show
cause.

I doubt you'll see cause you'll see profits.

1. Do not stop Neurontin without a physician assisting you
might suffer "status elipticus."
2. If you are suffering depression, suicidal ideation, and
or cardiac or other symptoms call your doctor now.
3. Demand what is right.

It is a pathetic shame that this travesty of justice continues.

Peace,

Karen G.
April 21st, 2005

"FDA requests Neurontin study data"


The FDA has requested 14 drugmakers to check their study data to see if use
of epilepsy drugs results in suicidal behavior or thoughts, giving the
drugmakers six months to respond.
Sales of anti-seizure drugs in the U.S. during 2004 were the fifth- largest
drug category, according to research firm IMS Health. Pfizer’s epilepsy drug
Neurontin was the best selling anti-seizure medication in 2004, followed by
Topamax.
Last year, a law firm asked the FDA to add a black box warning, the agency’s
strongest drug warning, about the suicide risks to Neurontin labels. After
giving the FDA 261 reports of people who had committed suicide while taking
Neurontin, with no attempted suicides prior to the medication, numerous personal
injury lawsuits against Pfizer regarding Neurontin were filed. About half of the
261 reported Neurontin users that committed suicide were taking the drug for
pain.
Pfizer says more than 10 million people have taken Neurontin, and currently
the drug’s prescribing information, a 29-page document that goes to doctors,
mentions “suicide gestures” as a rare adverse event. Rare adverse events are
considered fewer than one percent of 1,000 patients.
Pfizer’s Warner-Lambert division pleaded guilty to illegally marketing
Neurontin to treat ailments it was not FDA approved to treat last year.
Prosecutors
claim illegal Neurontin promotion boosted sales of the drug, contributing to
the 94 percent of prescriptions treating conditions other than FDA approved
reasons by 2002.

Karen Hallenbeck-Sikorsky-George BS,RN,UM,QC

http://hometown.aol.com/anewplanforyou
http://hometown.aol.com/anewplanforyou/sb.html


Owner-Moderator
http://groups.yahoo.com/group/ADayWithoutPain/
"ADayWithoutPain"
http://groups.yahoo.com/group/AnAnGeLInPain
"AnAnGeLInPain"

Ya'll are special you truly are, and to be the
catalyst for this group is a miracle for I know
in my heart that God's will created this group(s)
and each of you are very very special to me, always
no matter what I AM SO PROUD to a "part of" what
this family has become..AND WILL BE!!!!
Interqual Certified
Published Psychiatric Researcher
Advocate for those in CIP, HIV, Psychologic Pain
"A Higher Power is necessary to find the ability to withstand self
destruction.."


[Non-text portions of this message have been removed]